| Product NDC: | 0574-0014 |
| Proprietary Name: | Erythra-Derm |
| Non Proprietary Name: | Erythromycin |
| Active Ingredient(s): | 20 mg/mL & nbsp; Erythromycin |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0574-0014 |
| Labeler Name: | Paddock Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062687 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19880228 |
| Package NDC: | 0574-0014-02 |
| Package Description: | 1 BOTTLE in 1 CARTON (0574-0014-02) > 60 mL in 1 BOTTLE |
| NDC Code | 0574-0014-02 |
| Proprietary Name | Erythra-Derm |
| Package Description | 1 BOTTLE in 1 CARTON (0574-0014-02) > 60 mL in 1 BOTTLE |
| Product NDC | 0574-0014 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Erythromycin |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 19880228 |
| Marketing Category Name | ANDA |
| Labeler Name | Paddock Laboratories, Inc. |
| Substance Name | ERYTHROMYCIN |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |